Article
Low dose naltrexone for the treatment of fibromyalgia: Protocol for a double-blind, randomized, placebo-controlled trial
2021-04-08
Abstract excerpt
<title>Abstract</title> <p><bold>Background </bold>Low dose naltrexone (LDN) is used widely as off-label treatment for pain despite limited evidence for its effectiveness. A few small trials with high risk of bias have investigated the effect of LDN on pain associated with fibromyalgia in women, but larger and more methodologically robust studies are needed. The primary aim of this randomized controlled trial is...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- eda262ce-581e-5e6f-859e-43447b6fefd7
- DOI
- 10.21203/rs.3.rs-401663/v1
